《复牌公告》庄士中国(00298.HK)作价15.6亿人民币售番禺项目第三期
庄士中国(00298.HK)与庄士机构国际(00367.HK)联合公布,庄士中国向新加坡上市公司First Sponsor出售位於番禺名为庄士映蝶蓝湾之物业发展项目第三期,现金代价不多於15.64亿人民币(约18.77亿港元)。同时,向首铸及首诚出售位於该项目第一期总楼面面积约809平方米之水晶会所,以及一个停车位,现金代价不多於1,050万人民币(约1,260万港元)。
庄士中国估计出售收益净额10.79亿元,庄士机构应占收益净额约6.52亿元。
两公司股份申请周二(16日)起恢复买卖。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.